Integral Molecular Awarded $9.1 Million Contract from NIAID to Map Epitopes on Viral Pathogens using Shotgun Mutagenesis Mapping Technology
|
|
|
| Posted
:
Tue, 03 Nov 2009 15:40:36 GMT |
| Author
:
Integral Molecular, Inc.
|
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
| Press Release
News |
Home
|
|
|
|
PHILADELPHIA - (Business Wire) Integral Molecular, Inc. has been selected to receive a five year, $9.1 million contract from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health, to elucidate novel B cell epitopes on the surface of viral pathogens. Integral Molecular’s Shotgun Mutagenesis Mapping technology will be used to identify both linear and conformational epitopes on viral envelope proteins. By helping to define the full range of immunodominant structures on viral pathogens, Shotgun Mutagenesis will facilitate the design and development of improved vaccines against emerging infectious diseases. This is the second NIH award recently received by Integral Molecular for epitope mapping services. “Understanding the full range of viral epitopes targeted by the human immune system is vital to designing better viral vaccines,” said Dr. Benjamin Doranz, President of Integral Molecular. “This project will result in hundreds of new human antibodies against important viral proteins, high resolution epitope maps describing how these antibodies bind to their targets, and structural information about how these viral proteins function.” Shotgun Mutagenesis Mapping analyzes hundreds to thousands of variants of a target protein, each variant containing a unique amino acid substitution, to rapidly identify the binding residues that form antibody epitopes. This technology is well suited for epitope mapping viral envelope proteins, which usually form complex oligomeric structures and contain post-translational modifications that require expression within mammalian cells to retain their native conformation. Because Shotgun Mutagenesis maps functional proteins directly within living human cells, target proteins do not require purification or extraction from their native environment. About Integral Molecular Integral Molecular is a biotechnology company committed to providing innovative solutions for research and drug discovery applications involving membrane proteins. Integral Molecular was founded in 2001 and is located at the University City Science Center Research Park in Philadelphia. The company provides membrane protein-related products that help meet the scientific needs of pharmaceutical, biotechnology, and academic laboratories. Integral Molecular offers Shotgun Mutagenesis Mapping services on a fee-for service basis to the research community. More information about Shotgun Mutagenesis Mapping technology and Integral Molecular can be found at: www.integralmolecular.com.
Integral Molecular, Inc.
Benjamin Doranz, 215-966-6061
info@integralmolecular.com
www.integralmolecular.com
|
Copyright © 2008
Business Wire. All rights reserved.
|
|
|
|
|
Related
News
Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million
WASHINGTON, Nov. 23 /PRNewswire-USNewswire/ -- Febe Durango-Rueda, 52, a Colombian national, pleaded guilty on Nov. 20, 2009, to participating in a scheme to defraud the Export-Import Bank of the United States (Ex-Im Bank) of more than $1 million, announced Assistant Attorney General of...
Alpharetta Man Pleads Guilty to Impersonation of National Security Agent
Aprile Held Himself out to Alpharetta & Marietta Police Departments as Anti-Terrorism Task Force Leader
ATLANTA, Nov. 23 /PRNewswire-USNewswire/ -- Louis Joseph Aprile, 49, of Alpharetta, Ga., pleaded guilty today in federal district court to the offense of ...
Healthy Eating: Your Healthy Recipes Wanted by Healthy Life Network
CHICAGO, IL -- 11/23/09 --
Healthy Life Network, the new online source for
all that is healthy, is now accepting healthy recipe submissions from its
readers. Those
Dean Foods Company Chairman and CEO Completes Previously Disclosed Forward Sale Agreement
DALLAS, Nov. 23 -- Dean Foods Company (NYSE: DF) today announced that the previously disclosed variable prepaid forward sale contract entered into between Gregg Engles, Chairman and CEO and an unaffiliated third party on November 21, 2008 has partially settled...
Pinnacle Announces Third Quarter Earnings
SHERIDAN, Wyo., Nov. 23 -- Pinnacle Gas Resources, Inc. (Nasdaq: PINN) today reported the Company's financial results for the third quarter and nine months ended September 30, 2009 which included the following information:
Resul...
Closing Arguments Begin in the Trial of Khmer Rouge Official Kaing Guek Eav
CHICAGO, Nov. 23 /PRNewswire/ -- Northwestern University Law Professor David Scheffer is in Phnom Penh, Cambodia this week to analyze and provide commentary on closing arguments in the trial of Kaing Guek Eav (alias "Duch"). The trial, which began in March of t...
Health Net Reschedules Its Investor Day to February 11, 2010
LOS ANGELES -
Health Net, Inc. (NYSE:HNT) today announced that it is rescheduling its
annual Investor Day from December 11, 2009, to February 11, 2010. The
company expects to issue its 2010 earnings guidance on December 11, 2009.
“In light of the recent decision by the
|
|
|
|
|
|
|
|
|
